The companies will develop a mobile app that will allow patients to self-manage symptoms and enable remote monitoring by healthcare providers. In a phone interview, CEO Pierre Leurent touted the platform's broad applicability across different use cases.
Digital health companies faced bad news going into 2020, from job cuts to dissolving pharma partnerships. But these struggles are part of an industry that is finding its identity in a crowded healthcare market.
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
The company's software acts as an aid for cancer patients by helping users self-manage their disease symptoms and allow for remote monitoring by clinicians through mobile and web technologies.
Physicians prescribe the app developed by Voluntis to patients as part of an effort to help them manage their chronic condition.